W. H. Watt

Composite phaeochromocytoma-ganglioneuroma, an uncommon entity: report of two cases.

Raghwa N. Sharma, M. Bilous, P. Chin, 2010, Pathology.

Cytotoxic chemotherapy for advanced bladder cancer: cisplatin-containing regimens.

H. Mameghan, D. Raghavan, P. Langdon, 1991, Seminars in oncology.

Oral cyclophosphamide for the management of hormone-refractory prostate cancer.

J. Grygiel, A. Coates, D. Raghavan, 1993, British journal of urology.

Results of radiotherapy for localised prostatic carcinoma treated at the Prince of Wales Hospital, Sydney

R. Fisher, H. Mameghan, R. Farnsworth, 1991, The Medical journal of Australia.

Bowel complications after radiotherapy for carcinoma of the prostate: the volume effect.

R. Fisher, H. Mameghan, J. Mameghan, 1990, International journal of radiation oncology, biology, physics.

Vasoactive intestinal peptide and catecholamine secreting composite phaeochromocytoma – a case study and literature review

P. Chin, Dominic Lee, H. Mahajan, 2009 .

The management of invasive transitional cell carcinoma of the bladder. Results of definitive and preoperative radiation therapy in 390 patients treated at the prince of Wales hospital, Sydney, Australia

R. Fisher, H. Mameghan, E. Korbel, 1992, Cancer.

Prostate cancer detection in men with an initial diagnosis of atypical small acinar proliferation

S. Napaki, P. Chin, T. Skyring, 2007, BJU international.